A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma

A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma

Neuroblastoma is the most common extracranial solid malignancy of childhood. Approximately half of the patients have high-risk neuroblastoma (HR-NBL), typically presenting as widespread metastatic disease at diagnosis. Despite aggressive multimodality treatment, patients with HR-NBL have a long-term...

Full description

Bibliographic Details
Main Authors: Atia Samim, Gitta Bleeker, Kathelijne C.J.M. Kraal, Max M. van Noesel, Bart de Keizer, Godelieve A.M. Tytgat
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:EJC Paediatric Oncology
Subjects:
Neuroblastoma
Nuclear medicine
Radionuclide therapy
Theranostic
[131I]mIBG therapy
Metastasis
Online Access:http://www.sciencedirect.com/science/article/pii/S2772610X24000187

Internet

http://www.sciencedirect.com/science/article/pii/S2772610X24000187

Similar Items